Epigenetic control of heparanase expression through CRISPR/dCas9

被引：0
|
作者：
Zeng, Guihua [1 ]
Liang, Fu-Sen [2 ]
Cui, Lina [1 ]
机构：
[1] Univ Florida, Gainesville, FL USA
[2] Case Western Reserve Univ, Cleveland, OH 44106 USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-5234
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5234
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Application of Various Delivery Methods for CRISPR/dCas9
    Liu, Zhixi
    Liao, Zhi
    Chen, Yan
    Han, Lizhu
    Yin, Qinan
    Xiao, Hongtao
    MOLECULAR BIOTECHNOLOGY, 2020, 62 (08) : 355 - 363
  • [12] Application of Various Delivery Methods for CRISPR/dCas9
    Zhixi Liu
    Zhi Liao
    Yan Chen
    Lizhu Han
    Qinan Yin
    Hongtao Xiao
    Molecular Biotechnology, 2020, 62 : 355 - 363
  • [13] Epigenetic Targeting of Granulin in Hepatoma Cells by Synthetic CRISPR dCas9 Epi-suppressors
    Wang, Hong
    Guo, Rui
    Du, Zhonghua
    Bai, Ling
    Li, Lingyu
    Cui, Jiuwei
    Li, Wei
    Hoffman, Andrew R.
    Hu, Ji-Fan
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2018, 11 : 23 - 33
  • [14] Modeling of a Rare X-Linked Disorder for a CRISPR/dCas9 Based Epigenetic Rescue
    Gonzalez, Casiana E.
    Halmai, Julian A. N. M.
    Villegas, Isaac J.
    Halmai, Nicole B.
    Fink, Kyle D.
    MOLECULAR THERAPY, 2024, 32 (04) : 558 - 558
  • [15] Programmable activation of Bombyx gene expression using CRISPR/dCas9 fusion systems
    Wang, Xiao-Gang
    Ma, San-Yuan
    Chang, Jia-Song
    Shi, Run
    Wang, Ruo-Lin
    Zhao, Ping
    Xia, Qing-You
    INSECT SCIENCE, 2019, 26 (06) : 983 - 990
  • [16] CRISPR/dCas9 for hepatic fibrosis therapy: implications and challenges
    Luo, Nianan
    Zhong, Wenjun
    Li, Jiangbin
    Lu, Jianguo
    Dong, Rui
    MOLECULAR BIOLOGY REPORTS, 2022, 49 (12) : 11403 - 11408
  • [17] CRISPR/dCas9 for hepatic fibrosis therapy: implications and challenges
    Nianan Luo
    Wenjun Zhong
    Jiangbin Li
    Jianguo Lu
    Rui Dong
    Molecular Biology Reports, 2022, 49 : 11403 - 11408
  • [18] CRISPR/dCas9 Activated Expression of Cardiomyocyte Differentiation Factors in CDCs in Myocardial Infarctions
    Sano, T.
    Ishigami, S.
    Bandaru, S.
    Ito, T.
    Sano, S.
    EUROPEAN HEART JOURNAL, 2019, 40 : 3275 - 3275
  • [19] Activation of pluripotency genes using CRISPR/dCas9 system
    Vilarino, M.
    Meckler, J.
    Segal, D. J.
    Ross, J. P.
    TRANSGENIC RESEARCH, 2016, 25 (01) : 116 - 116
  • [20] CRISPR/dCas9 technologies for transcriptome manipulation and disease research
    Qi, S.
    PHYTOPATHOLOGY, 2016, 106 (12) : 176 - 176
12345